Results 121 to 130 of about 235,487 (237)
'What's on the label?' - the uptake and distribution of alcohol warning labels in Dublin retail stores following delay in policy implementation. [PDF]
Cordos LE +6 more
europepmc +1 more source
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct ...
Antonio Bruno +19 more
wiley +1 more source
Students' aerobic fitness, self-regulation, and mathematical performance in primary school. [PDF]
Kvalø SE +3 more
europepmc +1 more source
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu +10 more
wiley +1 more source
Assessment of Health Warning Label Compliance on Smokeless Tobacco Products in Bhubaneswar, India. [PDF]
Pattajoshi S, Jena PK, Mohapatra I.
europepmc +1 more source
Data‐Driven SuStaIn Model of Disability Progression in Amyotrophic Lateral Sclerosis
ABSTRACT Objective To determine whether ordinal Subtype and Stage Inference (SuStaIn) applied to routine ALSFRS‐R item scores can identify reproducible disability progression patterns in amyotrophic lateral sclerosis (ALS) and provide clinically meaningful staging.
Giammarco Milella +5 more
wiley +1 more source
Condition-associated modulation of melanin-based skin pigmentation in juvenile Atlantic salmon (<i>Salmo salar</i>). [PDF]
Gunnes M +3 more
europepmc +1 more source
Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini +9 more
wiley +1 more source
When feathers fell from fashion: unpacking the end of the UK plumage trade. [PDF]
Sinclair SL, Dickinson A, Veríssimo D.
europepmc +1 more source

